We are live on ! Find out more
GOSS icon

Gossamer Bio
GOSS

94 hedge funds and large institutions have $165M invested in Gossamer Bio in 2024 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 29

3% more call options, than puts

Call options by funds: $591K | Put options by funds: $576K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6.86% less ownership

Funds ownership: 87.69% → 80.83% (-6.9%)

15% less funds holding

Funds holding: 110 → 94 (-16)

29% less capital invested

Capital invested by funds: $234M → $165M (-$68.8M)

58% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 26

Holders
94
Holders Change
-16
Holders Change %
-14.55%
% of All Funds
1.36%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
11
Increased
31
Reduced
29
Closed
26
Calls
$591K
Puts
$576K
Net Calls
+$15K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$4.11M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$1.95M
3
6CM
683 Capital Management
New York
+$1.87M
4
NMC
NEA Management Company
Maryland
+$1.69M
5
MAM
Monaco Asset Management
Monaco
+$1.62M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$10.9M
2
FCM
Farallon Capital Management
California
-$7.23M
3
MAP
Madison Avenue Partners
New York
-$4.89M
4
Morgan Stanley
Morgan Stanley
New York
-$3.1M
5
MIM
Monashee Investment Management
Massachusetts
-$1.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
26
Monaco Asset Management
Monaco
$2.46M +$1.62M +2,170,104 +390%
LCM
27
Laurion Capital Management
New York
$2.22M +$122K +162,796 +7%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$2.06M – – –
Goldman Sachs
29
Goldman Sachs
New York
$1.91M -$431K -576,251 -21%
Renaissance Technologies
30
Renaissance Technologies
New York
$1.84M +$1.03M +1,375,000 +205%
Jacobs Levy Equity Management
31
Jacobs Levy Equity Management
New Jersey
$1.3M -$142K -189,467 -12%
DCM
32
DAFNA Capital Management
California
$1.27M – – –
Charles Schwab
33
Charles Schwab
California
$1.14M +$6.61K +8,833 +0.7%
SSA
34
Schonfeld Strategic Advisors
New York
$1.04M +$730K +975,678 +540%
EAM
35
Exome Asset Management
New York
$1.02M +$844K +1,127,699 New
MIM
36
Monashee Investment Management
Massachusetts
$775K -$1.95M -2,600,000 -75%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$742K -$252K -336,800 -29%
WP
38
Woodline Partners
California
$704K +$452K +603,836 +339%
Barclays
39
Barclays
United Kingdom
$693K +$576K +769,528 +769,528%
State Street
40
State Street
Massachusetts
$642K +$17.6K +23,525 +3%
NCM
41
Nantahala Capital Management
Connecticut
$623K – – –
TD Asset Management
42
TD Asset Management
Ontario, Canada
$578K +$164K +219,238 +52%
HCM
43
Highbridge Capital Management
New York
$538K – – –
BCM
44
Bridgeway Capital Management
Texas
$497K +$400K +535,000 +3,147%
ACM
45
ADAR1 Capital Management
Texas
$480K -$150K -200,000 -27%
Citigroup
46
Citigroup
New York
$450K -$1.34M -1,787,777 -78%
Northern Trust
47
Northern Trust
Illinois
$397K +$40.7K +54,457 +14%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$301K -$1.11M -1,478,811 -82%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$279K +$93.4K +124,913 +67%
Two Sigma Investments
50
Two Sigma Investments
New York
$279K -$373K -498,792 -62%
1
2
3 4 5

GOSS Hedge Fund Activity: Q2 2024 in Review

94 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q2 2024, worth a combined $165M — down 29% from $234M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of GOSS and 11 opened new positions — a net loss of 15 holders — while 29 trimmed existing stakes and 31 added.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $4.11M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $10.9M sold.

  • 94 institutional investors held Gossamer Bio (GOSS) as of Q2 2024, down from 110 in Q1 2024.
  • Funds reported $165M of Gossamer Bio stock for Q2 2024, down 29% quarter-over-quarter.
  • 11 funds opened new Gossamer Bio positions in Q2 2024 and 26 closed out, a net change of -15 holders.
  • The largest Gossamer Bio buyer in Q2 2024 was Alyeska Investment Group, an estimated $4.11M added.
  • The largest Gossamer Bio seller in Q2 2024 was EcoR1 Capital, an estimated $10.9M sold.

Based on aggregated 13F filings for Q2 2024.